The influence of doxorubicin and 4'-epi-doxorubicin on lipid peroxidation in mouse heart, lungs and liver. Part II. 1994

G Pierściński, and J Drzewoski, and D Nowak
Department of Clinical Pharmacology, Medical Academy, Lódź, Poland.

Influence of doxorubicin (DOX) and its less cardiotoxic analog 4'-epi-doxorubicin (EPI) on the peroxidation of cellular components was evaluated in vivo. Previous experimental work performed at our laboratory indicates that DOX, but not EPI, induces a marked increase in conjugated dienes formation (CD) in mice hearts exposed to a single intravenous dose (30 mg/kg) of that drug. Therefore, in the present study lipid peroxidation after treatment with these anthracyclines, was evaluated and compared in vivo by measuring the content of malondialdehyde (MDA) in heart, liver and lungs of Balb/c mice over 48-h period at various time-points: 5, 24 and 48 h after a single intravenous injection of either DOX or EPI. A statistically significant increased formation of MDA was found after both DOX and EPI in mice heart, lung and liver homogenates. DOX caused a relatively higher increase in MDA formation than did EPI. The results obtained in this study indicate that both DOX and EPI induce peroxidation of tissue components in vivo as shown by the increase in the formation of MDA. However, only DOX induces significant increase in lipid peroxidation in cardiac muscle, as assessed by the formation of CD. The results also suggest that peroxidation of other tissue components may be responsible for anthracycline-induced cardiotoxicity.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D008315 Malondialdehyde The dialdehyde of malonic acid. Malonaldehyde,Propanedial,Malonylaldehyde,Malonyldialdehyde,Sodium Malondialdehyde,Malondialdehyde, Sodium
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D005609 Free Radicals Highly reactive molecules with an unsatisfied electron valence pair. Free radicals are produced in both normal and pathological processes. Free radicals include reactive oxygen and nitrogen species (RONS). They are proven or suspected agents of tissue damage in a wide variety of circumstances including radiation, damage from environment chemicals, and aging. Natural and pharmacological prevention of free radical damage is being actively investigated. Free Radical
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

G Pierściński, and J Drzewoski, and D Nowak
March 1986, Mutation research,
G Pierściński, and J Drzewoski, and D Nowak
October 1982, Tumori,
G Pierściński, and J Drzewoski, and D Nowak
April 1983, Cancer treatment reports,
G Pierściński, and J Drzewoski, and D Nowak
March 1993, Indian journal of experimental biology,
G Pierściński, and J Drzewoski, and D Nowak
January 1987, Chemistry and physics of lipids,
G Pierściński, and J Drzewoski, and D Nowak
December 1984, Cancer treatment reports,
G Pierściński, and J Drzewoski, and D Nowak
January 1982, Farmakologiia i toksikologiia,
G Pierściński, and J Drzewoski, and D Nowak
January 2007, Acta poloniae pharmaceutica,
G Pierściński, and J Drzewoski, and D Nowak
May 1982, Cancer treatment reports,
G Pierściński, and J Drzewoski, and D Nowak
January 1984, Investigational new drugs,
Copied contents to your clipboard!